The National Institutes of Health agreed to reassess hundreds of grant applications that had been paused after new administration directives limited funding for research involving diversity, gender identity and certain topics. The settlement follows litigation by scientific organizations and plaintiffs; the NIH will review the applications on scientific merit and set aside the challenged directives for those reviews. The agreement does not compel funding but restores the normal peer‑review pathway for affected proposals covering areas from Alzheimer’s to minority health. Plaintiffs and researchers have framed the outcome as a corrective step to preserve merit‑based grant evaluation.